Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study


SAVLI H. , Galimberti S., Sunnetci D. , Canestraro M., Palumbo G., Nagy B., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.3, pp.206-212, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.4274/tjh.2014.0058
  • Title of Journal : TURKISH JOURNAL OF HEMATOLOGY
  • Page Numbers: pp.206-212

Abstract

Objective: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39.